Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

被引：1
作者：
Maguire, Maureen G. [1 ]
机构：
[1] Univ Penn, Dept Ophthalmol, 3535 Market St,Ste 700, Philadelphia, PA 19104 USA
来源：
JAMA OPHTHALMOLOGY | 2018年 / 136卷 / 08期
关键词：
RANIBIZUMAB; BEVACIZUMAB; OUTCOMES; CATT;
D O I：
10.1001/jamaophthalmol.2018.0032
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：884 / 885
页数：3
相关论文
共 9 条
[1]   Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration [J].
Avery, RL ;
Pieramici, DJ ;
Rabena, MD ;
Castellarin, AA ;
Nasir, MA ;
Giust, MJ .
OPHTHALMOLOGY, 2006, 113 (03) :363-372
[2]   Genetics of Age-Related Macular Degeneration: Current Concepts, Future Directions [J].
DeAngelis, Margaret M. ;
Silveira, Alexandra C. ;
Carr, Elizabeth A. ;
Kim, Ivana K. .
SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) :77-93
[3]   Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration [J].
Finger, Robert P. ;
Wickremasinghe, Sanjeewa S. ;
Baird, Paul N. ;
Guymer, Robyn H. .
SURVEY OF OPHTHALMOLOGY, 2014, 59 (01) :1-18
[4]   Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration [J].
Heier, Jeffrey S. ;
Brown, David M. ;
Chong, Victor ;
Korobelnik, Jean-Francois ;
Kaiser, Peter K. ;
Quan Dong Nguyen ;
Kirchhof, Bernd ;
Ho, Allen ;
Ogura, Yuichiro ;
Yancopoulos, George D. ;
Stahl, Neil ;
Vitti, Robert ;
Berliner, Alyson J. ;
Soo, Yuhwen ;
Anderesi, Majid ;
Groetzbach, Georg ;
Sommerauer, Bernd ;
Sandbrink, Rupert ;
Simader, Christian ;
Schmidt-Erfurth, Ursula .
OPHTHALMOLOGY, 2012, 119 (12) :2537-2548
[5]   Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration [J].
Lores-Motta, Laura ;
Riaz, Moeen ;
Grunin, Michelle ;
Corominas, Jordi ;
van Asten, Freekje ;
Pauper, Marc ;
Leenders, Mathieu ;
Richardson, Andrea J. ;
Muether, Philipp ;
Cree, Angela J. ;
Griffiths, Helen L. ;
Pham, Connie ;
Belanger, Marie-Claude ;
Meester-Smoor, Magda A. ;
Ali, Manir ;
Heid, Iris M. ;
Fritsche, Lars G. ;
Chakravarthy, Usha ;
Gale, Richard ;
McKibbin, Martin ;
Inglehearn, Chris F. ;
Schlingemann, Reinier O. ;
Omar, Amer ;
Chen, John ;
Koenekoop, Robert K. ;
Fauser, Sascha ;
Guymer, Robyn H. ;
Hoyng, Carel B. ;
de Jong, Eiko K. ;
Lotery, Andrew J. ;
Mitchell, Paul ;
den Hollander, Anneke I. ;
Baird, Paul N. ;
Chowers, Itay .
JAMA OPHTHALMOLOGY, 2018, 136 (08) :875-884
[6]   Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group [J].
Martin, Daniel F. ;
Maguire, Maureen G. ;
Ying, Gui-shuang ;
Grunwald, Juan E. ;
Fine, Stuart L. ;
Jaffe, Glenn J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20) :1897-1908
[7]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[8]   Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) [J].
Ying, Gui-shuang ;
Maguire, Maureen G. ;
Daniel, Ebenezer ;
Ferris, Frederick L. ;
Jaffe, Glenn J. ;
Grunwald, Juan E. ;
Toth, Cynthia A. ;
Huang, Jiayan ;
Martin, Daniel F. .
OPHTHALMOLOGY, 2015, 122 (12) :2523-+
[9]   Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration [J].
Ying, Gui-shuang ;
Huang, Jiayan ;
Maguire, Maureen G. ;
Jaffe, Glenn J. ;
Grunwald, Juan E. ;
Toth, Cynthia ;
Daniel, Ebenezer ;
Klein, Michael ;
Pieramici, Dante ;
Wells, John ;
Martin, Daniel F. .
OPHTHALMOLOGY, 2013, 120 (01) :122-129
1